Abbott, Inc.: LibreView for US Government
FedRAMP AuthorizedRev5Moderate · since May 12, 2020
What its stage means
An agency or the FedRAMP program authorized it. Agencies can reuse that authorization.
The provider's description
LibreView is intended for use by patients, caregivers and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. LibreView is developed, distributed, and supported by Abbott, a major manufacturer of glucose monitoring devices. Trademarks are the property of their respective owners.
What FedXchange has recorded
No change since FedXchange began following it on April 14, 2026. Each change of stage, impact level, or number of authorizations appears here.